Business UpdateJun 24, 2026, 03:38 PM
Cosmos Health C-Sept PRO Annualized Sales Exceed $1.3M, 72% Gross Margin
AI Summary
Cosmos Health Inc. provided an update on the strong momentum of its C-Sept™ PRO antiseptic solution in Greek hospitals. The product is on track for annualized sales exceeding $1.3 million, generating approximately $0.9 million in annualized gross profit with a gross margin of about 72%. Demand is driven by adoption across major public and private Greek hospital groups and consistent repeat ordering. The company intends to expand its hospital-focused antiseptics business into additional European markets.
Key Highlights
- C-Sept PRO annualized sales are on track to exceed $1.3 million.
- The product generates approximately $0.9 million in annualized gross profit.
- C-Sept PRO has a gross margin of approximately 72%.
- Average monthly sales exceeded $93,000 over the past six months.
- Average monthly sales accelerated to over $108,000 per month over the past three months.
- The company plans to extend its hospital-focused antiseptics business into additional European markets.
Price Impact
More from COSM